📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
TRIDENT TEXOFAB LIMITEDTTFLOther Textile Products
Open
48.11
High
48.11
Low
44.5
Close
47.88
Volume
91128
Exchange
bse
Time
01-Apr-2026

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Trident Texofab is  
High Wave
Estimated Stoploss of Trident Texofab is ₹  
48.11
Trident Texofab has a  
Bearishℹ
 pattern. 
Formation of  
High Wave
 candle pattern indicates the trend direction of Trident Texofab is  
Unpredictableℹ
. 

Trend

Trident Texofab is in  
Sideways trendℹ
. 
Price of Trident Texofab is  
Downℹ
 by  

50.64

%. 
Target
Sell @ 

315.87

Current @ 

47.88

Volume

The trades of Trident Texofab have been in  
Immenseℹ
 volume. 
The volume trades for Trident Texofab are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Trident Texofab is  

Up

 by  

158.39

% 

Valuation

The current market price of Trident Texofab is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 100cr and total assets worth ₹ 100cr, the balance sheet of Trident Texofab is:  
Balancedℹ
. 
Cashflow
Trident Texofab has  
Sufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

40.63% in operatingℹ
3.13% in investingℹ
56.25% in financingℹ
0% in otherℹ
Trident Texofab has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

50% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
50% i.e. ₹ 2cr spent in financingℹ
0% in otherℹ
Income
The income of Trident Texofab is  

₹ 31cr

 and  

Profit

 is :  

₹ 1cr

(*Sep 2025)

Trident Texofab Profit is up by:  

100

% and Income is Down by:  

26.32

% 

(*Sep 2025)

The income of Trident Texofab is  

₹ 28cr

 and  

Loss

 is :  

₹ 1cr

(*Jun 2025)

Trident Texofab Losses increased by:  

0

% and Income is Up by:  

22.58

% 

(*Jun 2025)

The income of Trident Texofab is  

₹ 38cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Trident Texofab Losses increased by:  

100

% and Income is Up by:  

6.9

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.